Related Experiment Video
Updated: Sep 29, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Spectrum of COVID-19 Disease in Children: A Retrospective Analysis Comparing Wave 1 and Wave 2 from a Tertiary
Murugan T P1, Urmi Ghosh1, Roshni Julia Rajan1
1Department of Pediatrics, Christian Medical College, Vellore, Tamil Nadu, 632004, India.
Insights
COVID-19 in children showed similar severity across two waves, but the second wave saw a significant increase in mortality. Symptoms like fever and cough were more common in the second wave.
Area of Science:
- Pediatric Infectious Diseases
- Epidemiology
- Public Health
Background:
- The COVID-19 pandemic impacted children globally, with varying clinical presentations and outcomes observed across different waves.
- Understanding pediatric COVID-19 characteristics is crucial for effective public health management and clinical care.
Purpose of the Study:
- To compare the clinical and epidemiological features of COVID-19 in children during the first and second waves of the pandemic.
- To identify differences in symptoms, disease severity, and mortality rates between the two waves.
Main Methods:
- Retrospective review of electronic medical records for children under 16 with confirmed COVID-19 infection.
- Data collection included demographics, clinical signs, laboratory results, and treatment requirements.
- Analysis compared outcomes between the first wave (June 2020-Feb 2021) and the second wave (March 2021-May 2021).
Main Results:
- A total of 988 children were diagnosed with COVID-19.
- The second wave (403 children) showed significantly higher rates of fever, cough, coryza, and elevated heart rate and temperature compared to the first wave (585 children).
- While disease severity and need for intensive care were similar, mortality was significantly higher in the second wave (2%) versus the first wave (0.3%).
Conclusions:
- Pediatric COVID-19 exhibited similar disease severity during the first and second waves.
- A notable increase in mortality was observed during the second wave among children.
- Differences in symptom prevalence were noted between the two pandemic waves.
Objective:
To describe COVID-19 in children and the differences between the two waves.
Methods:
The electronic medical records of children younger than 16 y of age with laboratory-confirmed COVID-19 infection between June 1st 2020 and May 31st 2021 at Christian Medical College, Vellore were retrospectively reviewed. Demographic, clinical, and laboratory data were collected on a predesigned case record form and analyzed.
Results:
A total of 988 children were diagnosed with confirmed COVID-19 during the study period. Of these, there were 585 children diagnosed during the 1st wave (June 2020-Feb 2021) and 403 children during the 2nd wave (March 2021-May 2021). It was found that loose stools and rash were significantly more frequent during the 1st wave and fever, cough, coryza, heart rate and temperature were significantly more during the 2nd wave. There was no significant difference between the two groups in terms of requirement of oxygen therapy, need for ICU admission, duration of ICU stay or hospital stay, or severity of illness. Mortality was significantly higher during the 2nd wave (0.3% vs. 2%).
Conclusion:
The COVID-19 pandemic among children during the 1st and 2nd waves were similar in severity, though there was a higher mortality during the 2nd wave.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tonsillitis II: Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause: